Should we stop taking thiazides to prevent kidney stones?

Published Date: 08 Mar 2023

"Thiazide is the standard treatment for calcium stones, so this [new research] has the potential to upset the basket," one observer said.

Read Full News

Latest News

GLP-1 vs DPP-4 Meds: Which Is Better for Diabetes Control?

Sustained GLP-1 receptor agonist therapy is linked to greater improvements in A1c levels than DPP-4 inhibitor therapy in patients with type 2 diabetes, a Danish real-world analysis shows.

Lilly Launches Employer-connect Platform to Broaden Weight-loss Drug Access

Eli Lilly said on Thursday it has rolled out a platform to help employers connect ⁠with organizations offering low-cost benefits and comprehensive obesity-care programs,...

Pharmacist-Led Model Lowers Treatment-Related Hypoglycemia

A collaborative intervention model involving a clinical pharmacist significantly reduces severe hypoglycemia risk without compromising glycemic control.

Bariatric Surgery Rates Fall as GLP-1s Gain Popularity

The use of GLP 1s increased dramatically from 2018 to 2025 among patients eligible for metabolic and bariatric surgery in the US, whereas surgery rates declined notably.

‘Generation GLP-1’ Drives GLP-1-Friendly Food Marketing

Experts warn the label is ‘more marketing than medical’; urge following evidence on nutritional recommendations for GLP-1 therapy.

Lobectomy: Viable Alternative in Medullary Thyroid Carcinoma

Thyroid lobectomy may provide oncologic outcomes similar to those of total thyroidectomy in patients with sporadic medullary thyroid carcinoma, per a meta-analysis of 1371 patients from nine studies.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Latest News

Sustained GLP-1 receptor agonist therapy is linked to greater improvements in A1c levels than DPP-4 inhibitor therapy in patients with type 2 diabetes, a Danish real-world analysis shows.

Eli Lilly said on Thursday it has rolled out a platform to help employers connect ⁠with organizations offering low-cost benefits and comprehensive obesity-care programs,...

A collaborative intervention model involving a clinical pharmacist significantly reduces severe hypoglycemia risk without compromising glycemic control.

The use of GLP 1s increased dramatically from 2018 to 2025 among patients eligible for metabolic and bariatric surgery in the US, whereas surgery rates declined notably.

Experts warn the label is ‘more marketing than medical’; urge following evidence on nutritional recommendations for GLP-1 therapy.

Thyroid lobectomy may provide oncologic outcomes similar to those of total thyroidectomy in patients with sporadic medullary thyroid carcinoma, per a meta-analysis of 1371 patients from nine studies.

News All Time

Patient-Centered Approaches in Obesity Case Management

Nonjudgmental and collaborative care plans are ideal for primary care clinicians treating patients with obesity.

Can OTC Remedies Help With GLP-1 Adherence?

GI side effects from GLP-1s may cause patients to drop the medications or turn to OTC remedies. Gastroenterologists don’t rule them out but also cite lack of evidence.

Widely Used Procedure Questionable for Pancreatitis Patients

Pivotal study shows no clear benefit for the common endoscopic procedure in this patient group. Experts say the new data could help avoid unnecessary cost and risk.

Novel GLP-1 Promising for Reducing Weight, Glucose

A new GLP-1 drug showed superior efficacy in reducing A1c and weight in patients with T2D.

Problems Arise at the Intersection of Alcohol and GLP-1s

Alcohol often blocks or counters the effects of weight-loss drugs and taxes liver and kidney function.

Changes in Body Image and Pain Tied to Depression in Cushing

A recent longitudinal cohort study shows a statistically significant relationship between body image disturbance, pain, and persistent depression in patients with Cushing syndrome.

What Boosts Adherence to GLP-1s?

GLP-1s sometimes cause unpleasant side effects that can lead to nonadherence and discontinuation, but some patients stay the course anyway. What factors motivate them not to give up?

Big Breakfast Alters Appetite, Gut Health

Breakfast meals higher in protein promote feelings of satiety, and those higher in fiber boost beneficial gut microbiota — both lead to weight loss and metabolic benefits.

Diabetes and Mental Health Care Gaps Exposed

A national investigation has found that gaps between diabetes and mental health services are exposing insulin-treated adults to avoidable harm and death.

US FDA Approves Eton's Liquid Therapy for Rare Water-balance Disorder

The U.S. Food and Drug Administration on Wednesday approved Eton Pharmaceuticals' first-of-its-kind liquid therapy for a ⁠rare hormonal disorder, offering a more precise...

Nearly a Third of US Youth Have Prediabetes or Diabetes

Nearly 1 in 3 US adolescents have prediabetes or type 2 diabetes, with abdominal adiposity being the strongest independent predictor, analysis of national survey data from 2021 to 2023 shows.

Gut Flora May Be Altered by Oral Semaglutide Additive

Salcaprozate sodium, the absorption-enhancing ingredient used in oral semaglutide, is associated with changes in gut microbiota and inflammatory markers in a preclinical study.

ChatGPT Excels at Classifying Ultraprocessed Foods

ChatGPT accurately classifies foods by processing level and detects ultraprocessed items, which may help automate and improve future dietary research.

Targeted Tablet Approved for ESR1 Breast Cancer

MHRA approval of imlunestrant offers a new option for patients with ESR1-mutated, ER-positive advanced breast cancer.

GPs ‘Reeling’ Over New Contract in England

A new GP contract for England promises same-day urgent appointments, but medical leaders warn it raises unrealistic expectations and workload risks.

Recommended News For You

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

New tumor therapy approach reduces costs and side effects while increasing accessibility

Achieves a High Disease Control Rate in Head and Neck BCC with Vismodegib-RT Regimen.

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.

Avoiding Neuropathy From Chemo; Predictive Value of Screening EKGs

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

Recommended Articles For You

Understanding Macrocytosis: Causes, Symptoms, and Treatment Options  

Unmasking the Subtle Symptoms of Colon Cancer 

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy 

Revolutionizing Cancer Treatment: How Adoptive Cell Therapy is Overcoming Tumor Immune Evasion 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Including Isatuximab with a Standard Backbone Enhances Multiple Myeloma Results.

2.

Charting the Course: From Young Adult Leukemia Patient to Oncologist.

3.

Screening for prostate cancer: is it time to give up digital rectal examination?

4.

Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care

5.

Charles III, King of Kings, is Cancerous.

1.

The Growing Crisis of Aplastic Anemia: A Call for Action

2.

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis

3.

Hemophilia Beyond Boundaries: Unconventional Therapies in Bleeding Disorder Care

4.

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer

5.

Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

2.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

3.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

4.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part V

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot